Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32451
A Survey Proposal towards Holistic Management of Schizophrenia

Authors: Pronab Ganguly, Ahmed A. Moustafa


Holistic management of schizophrenia involves mainstream pharmacological intervention, complimentary medicine intervention, therapeutic intervention and other psychosocial factors such as accommodation, education, job training, employment, relationship, friendship, exercise, overall well-being, smoking, substance abuse, suicide prevention, stigmatisation, recreation, entertainment, violent behaviour, arrangement of public trusteeship and guardianship, day-day-living skill, integration with community, and management of overweight due to medications and other health complications related to medications amongst others. Our review shows that there is no integrated survey by combining all these factors. An international web-based survey was conducted to evaluate the significance of all these factors and present them in a unified manner. It is believed this investigation will contribute positively towards holistic management of schizophrenia. There will be two surveys. In the pharmacological intervention survey, five popular drugs for schizophrenia will be chosen and their efficacy as well as harmful side effects will be evaluated on a scale of 0 -10. This survey will be done by psychiatrists. In the second survey, each element of therapeutic intervention and psychosocial factors will be evaluated according to their significance on a scale of 0 - 10. This survey will be done by care givers, psychologists, case managers and case workers. For the first survey, professional bodies of psychiatrists in English speaking countries will be contacted to request them to ask their members to participate in the survey. For the second survey, professional bodies of clinical psychologist and care givers in English speaking countries will be contacted to request them to ask their members to participate in the survey. Additionally, for both the surveys, relevant professionals will be contacted through personal contact networks. For both the surveys, mean, mode, median, standard deviation and net promoter score will be calculated for each factor and then presented in a statistically significant manner. Subsequently each factor will be ranked according to their statistical significance. Additionally, country specific variation will be highlighted to identify the variation pattern. The results of these surveys will identify the relative significance of each type of pharmacological intervention, each type of therapeutic intervention and each type of psychosocial factor. The determination of this relative importance will definitely contribute to the improvement in quality of life for individuals with schizophrenia.

Keywords: Schizophrenia, holistic management, antipsychotics, quality of life.

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 704


[1] Shenton, E. M., Kikinis, R., Jolesz, A. F., Pollak, D. S., LeMay, Wible, G., Hokama, H., Martin, J., Metcalf, D., Coleman, M., McCarley. W. R., Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia — A Quantitative Magnetic Resonance Imaging Study, N Engl J Med, 1992, 327,604-612.
[2] American Psychiatric Association, Diagnostic and statistical manual of mental disorders (5th Ed.) 2013. Arlington, VA: American Psychiatric Publishing.
[3] Mathers, C. D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3, 2006: e442.
[4] Simeone, J. C., Ward, A. J., Rotella, P., Collins, J., Windisch, R., An evaluation of variation in published estimates of schizophrenia prevalence from 1990 - 2013: A systematic literature review, BMC Psychiatry, 2015, 15: 193.
[5] Kirkbride, J. B., Fearon, P., Morgan, C., Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study, Archives of General Psychiatry,2006, 63: 250–258.
[6] Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, A., Kulkarni, J., McGorry, P., Nielssen, O., Tran, N. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders; doi: 10.1177/0004867416641195 Aust N Z J Psychiatry May 2016 vol. 50 no. 5 410-472.
[7] Aleman, A., Kahn, R. S., Selten, J. P., Sex differences in the risk of schizophrenia: Evidence from meta-analysis, Archives of General Psychiatry, 2003, 60: 565–571.
[8] McGrath, J. L., Saha, S., Chant, D., Welham, J. Schizophrenia: A concise overview of incidence, prevalence, and mortality, Epidemiologic Reviews, 2008, 30: 67–76.
[9] Neil AL, Carr VJ, Mihalopoulos C, What difference a decade? The costs of psychosis in Australia in 2000 and 2010: Comparative results from the first and second Australian national surveys of psychosis., Australian and New Zealand Journal of Psychiatry, 2014, 48: 237–248.
[10] Khandakera, M. G., Barnetta, H., Whitec, R. I., Jonesa, B. P., A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia, Schizophrenia Research; 2011, 132(2–3), 220–227.
[11] Cieslak, Kristina, Jordyn, Feingold, Daniel, Antonius, Julie, Walsh-Messinger, Roberta, Dracxler, Mary, Rosedale, Nicole, Aujero, David, Keefe, Deborah, Goetz, Raymond, Goetz, Dolores, Malaspina, Low Vitamin D levels predict clinical features of schizophrenia; Schizophrenia Research; November 2014,Volume 159, Issues 2-3, Pages 543–545.
[12] Turkington, D., Kingdon, D., Weiden, P. J., Cognitive behavior therapy for schizophrenia. Am J Psychiatry, 2006;163:365–373.
[13] Lewis, S., Tarrier, N., Haddock, G., Randomised controlled trial of cognitive–behavioural therapy in early schizophrenia: acute-phase outcomes, British Journal of Psychiatry, 2002, 181 (suppl. 43), s91–s97.
[14] Teesson, M. L., Hodder, T., Buhrich, N., Psychiatric disorders in homeless men and women in inner Sydney. Australian and New Zealand Journal of Psychiatry, 2004, 38: 162–168.
[15] Morrison, K. Ann; Cognitive Behavior Therapy for People with Schizophrenia; Psychiatry (Edgmont). 2009 Dec; 6(12): 32–39.
[16] Gangadhar, N., Varambally, S., Int J Yoga. 2012 Jul-Dec; 5(2): 85–91.
[17] Fontanella CA1, Guada J, Phillips G, Ranbom L, Fortney JC , Individual and contextual-level factors associated with continuity of care for adults with schizophrenia, Adm Policy Ment Health. 2014 Sep;41(5):572-87.
[18] Kinoshita, Y., Furukawa, T. A., Kinoshita, K., Honyashiki, M., Omori, I. M., Marshall, M., Bond, G. R., Huxley, P., Amano, N., Kingdon, D., Supported employment for adults with severe mental illness,2013, The Cochrane Database of Systematic Reviews 9: CD008297.
[19] Drake, E. R., Bond, R. G., and Becker, R. D., Individual Placement and Support: An Evidence-Based Approach to Supported Employment, 2012, New York: Oxford University Press.
[20] Lysaker PH, Davis LW, Bryson GJ, Bell MD. Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders. Schizo Res. 2009;107:186–191.
[21] Ramsay, C. E., Broussard, B., Goulding, S. M., Cristofaro, S., Hall, D., Kaslow, N. J., Killackey, E., Penn, D., Compton, M. T., Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis, Psychiatry Research , 2011,189: 344–348.
[22] Koschorke M, Padmavati R, Kumar S, Cohen A, Weiss HA, Chatterjee S, Pereira J, Naik S, John S, Dabholkar H, Balaji M, Chavan A, Varghese M, Thara R, Patel V, Thornicroft G.; Experiences of stigma and discrimination faced by family caregivers of people with schizophrenia in India.; Soc Sci Med. 2017 Apr;178:66-77. doi: 10.1016/j.socscimed.2017.01.061. Epub 2017 Feb 1.
[23] Mamo DC, Managing suicidality in schizophrenia. Can J Psychiatry. 2007;52(6) 1:59S–70S.
[24] Large M, Smith G, Nielssen O, The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: A systematic review and meta-analysis, Schizophrenia Research,2009, 112: 123–129.
[25] Eack SM, Mesholam-Gately RI, Greenwald DP, Negative symptom improvement during cognitive rehabilitation: Results from a 2-year trial of Cognitive Enhancement Therapy, Psychiatry Research, 2013, 209: 21–26.
[26] Manjunath, R. B., Psychiatry, National Institute of Mental Health and Neurosciences; 2009. Efficacy of yoga therapy as an add-on treatment for in-patients and out-patients with functional psychotic disorder (Dissertation).
[27] Moore, E., Mancuso, S. G., Slade, T. The impact of alcohol and illicit drugs on people with psychosis: The second Australian National Survey of Psychosis, Australian and New Zealand Journal of Psychiatry, 2012, 46: 864–878.
[28] Reichheld FF, The one number you need to grow; Harvard Business Review.2003 , Dec; 81(12):46-54, 124.